Focus: Cytrellis Biosystems is a medical device company focused on aesthetic dermatology, headquartered in Woburn, MA. The company develops micro-coring technology platforms for wrinkle reduction, scar treatment, and skin laxity.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
0 added, 3 removed. Backfill posture.
Cytrellis represents a niche aesthetic device play with commercial momentum, but lack of financial transparency and small hiring footprint create career risk for those seeking scale or security.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship micro-coring device with multiple clinical trial programs spanning wrinkle reduction and histopathology assessment.
Help build intelligence for Cytrellis Biosystems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cytrellis Biosystems's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Multi-indication platform technology addressing three high-demand aesthetic concerns with separate clinical programs.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles